✦ LIBER ✦

Characterization of a new LCAT mutation causing familial LCAT deficiency (FLD) and the role of APOE as a modifier gene of the FLD phenotype

✍ Scribed by Alexis Baass; Hanny Wassef; Michel Tremblay; Lise Bernier; Robert Dufour; Jean Davignon

Book ID: 118422587
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 420 KB
Volume: 207
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2009.05.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

C14 Two novel mutations of the lecithin:

C14 Two novel mutations of the lecithin:cholesterol acyltransferase (LCAT) gene causing familial LCAT deficiency (FLD): Section 1

✍ M Rolleri; A Cantafora; G Franceschini; L Calabresi; G Boscutti; R Mioni; S Pizz 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

C15 Two novel mutations of the lecithin:

C15 Two novel mutations of the lecithin:cholesterol acyltransferase (LCAT) gene causing familial LCAT deficiency (FLD): Section 2

✍ M Rolleri; A Cantafora; G Franceschini; L Calabresi; G Boscutti; R Mioni; S Pizz 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

W07-P-006 Familial lecithin-cholesterol

W07-P-006 Familial lecithin-cholesterol acyltransferase deficiency: Characteristics of the carriers of a new LCAT gene mutation from a polish family

✍ Idzior-Walus, B.; Sieradzki, J.; Kostner, G.; Małecki, M.; Klupa, T.; Wesołowska 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 258 KB

The molecular basis of familial hypercho

The molecular basis of familial hypercholesterolemia in Lebanon: Spectrum of LDLR mutations and role of PCSK9 as a modifier gene

✍ Marianne Abifadel; Jean-Pierre Rabès; Sélim Jambart; Georges Halaby; Marie-Hélèn 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB 👁 1 views

Autosomal dominant hypercholesterolemia (ADH), a major risk for coronary heart disease, is associated with mutations in the genes encoding the low-density lipoproteins receptor (LDLR), its ligand apolipoprotein B (APOB) or PCSK9 (Proprotein Convertase Subtilin Kexin 9). Familial hypercholesterolemia